Serum_bioactive_and_immunoreactive_luteinizing_hormone_and_follicle-stimulating_hormone_levels_in_women_with_cycle_abnormalities,_with_or_without_polycystic_ovarian_disease._Serum_steroid,_gonadotropin,_and_alpha-subunit_levels_were_assessed_in_35_women_with_cycle_abnormalities_11_with_and_24_without_polycystic_ovarian_disease_(PCOD)_according_to_strict_clinical_and_biochemical_criteria_and_8_regularly_cycling_women_in_the_early_(cycle_day_3_or_4)_and_mid_(cycle_day_7_or_8)_follicular_phase._LH_and_FSH_levels_were_estimated_using_two_immunological_techniques_RIA_and_immunoradiometric_assay_(IRMA)_and_in_vitro_bioassays_(BIO),_using_mouse_Leydig_cells_and_rat_granulosa_cells,_respectively._In_PCOD_patients_mean_alpha-subunit,_free_androgen_index_FAI;_testosterone_x_100/sex_hormone-binding_globulin_(SHBG),_androstenedione,_estrone,_and_estradiol_(E2)_were_significantly_elevated_compared_to_levels_in_the_early_follicular_phase_of_control_cycles_and_non-PCOD_patients._In_addition,_in_PCOD_patients_mean_IRMA-LH_and_RIA-LH_levels_were_distinctly_increased_(2.8-_to_3.6_fold,_respectively;_both_comparisons,_P_less_than_0.001)_compared_to_control_values,_but_in_the_same_order_of_magnitude_(1.3-_to_1.4-fold_increments)_as_that_in_non-PCOD_patients._However,_the_median_BIO-LH_level_in_PCOD_patients_was_5.9-fold_higher_than_that_in_non-PCOD_patients_and_4.0-fold_higher_than_the_BIO-LH_in_the_early_follicular_phase_of_control_women._Consequently,_the_median_BIO/IRMA-LH_ratio_was_4.8-fold_higher_in_PCOD_patients_compared_to_non-PCOD_patients._In_women_with_cycle_abnormalities,_individual_BIO/IRMA-LH_ratios_correlated_with_BIO-LH_(rs_=_0.48),_FAI_(rs_=_0.39),_free_estrogens_(E2/SHBG_ratios;_rs_=_0_0.47),_and_dehydroepiandrosterone_sulfate_(rs_=_0.60)_concentrations._Mean_IRMA-,_RIA-,_and_BIO-FSH_levels_and_BIO/IRMA-FSH_ratios_were_not_significantly_different_when_various_groups_were_compared._Although_RIA-_and_IRMA-LH_levels_showed_good_correlation_(rs_=_0.88),_RIA-LH_levels_were_consistently_higher,_resulting_in_distinctly_higher_RIA-LH/FSH_ratios_(mean,_4.5)_compared_to_IRMA-LH/FSH_ratios_(median,_1.8)_in_PCOD_patients.(ABSTRACT_TRUNCATED_AT_400_WORDS).